Webinar – Getting GRIP on MASH after LITMUS
On March 12th, we organised the webinar: Getting GRIP on MASH after LITMUS
During this webinar, our speaker and hosts explored the following topics:
- The usefulness of noninvasive diagnostic methods depends on the prevalence of the disease
- Intervention in lifestyle helps to better stratify patients
- Clinical pathways from primary care or endocrinology clinics improves MASH management
Speakers, hosts, and audience
- Speaker: Prof. Manuel Romero-Gómez
- Hosts: Prof. Manuel Castro Cabezas & Prof. Rick Grobbee
- Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers
Watch the recording here:
Related
ESC 2026 Takeaways: Precision Prevention, Smarter Risk Assessment, and the Evolving Future of Cardiovascular Trials
The P95 Julius Clinical team recently joined researchers, sponsors, clinicians, and industry leaders in Munich for ESC Congress 2026. Across scientific sessions, new clinical guidance, and industry discussions, several themes emerged that could in...
Beyond Weight Loss: Why the Next Phase of Cardiometabolic Innovation Will Be Defined by Outcomes
With obesity affecting more than one billion people globally and the market for obesity therapeutics projected to grow dramatically over the next decade, the stakes for sponsors have never been higher. Driven by breakthrough therapies, rapid marke...
How CROs Help Sponsors Reduce the Operational Risks of MASH Clinical Trials
Drawing on the experience and perspectives of Prof. Dr. Manuel Castro Cabezas, Scientific Officer at P95 Julius Clinical, and Prof. Dr. Diederick (Rick) E. Grobbee, Chief Scientific Officer at P95 Julius Clinical, this article explores how sponsor...